Arcelor Acquires Controlling Stake in Brazilian Stainless Steel Producer Acesita

On October 26, 2005, Arcelor agreed with the Brazilian pension fund Fundação Sistel de Seguridade Social ("Sistel") to acquire the 12% of the voting capital of Acesita held by Sistel for R$45 per share. As a result, Arcelor will become the controlling shareholder of Acesita, holding 76% of the common (voting) shares of Acesita and 40 percent of the total capital of that company.

The move follows the agreement, on October 6, 2005, with Previ and Petros, two other Brazilian pension funds to acquire common shares representing 25% of the Brazilian stainless steel producer's voting capital and 8% of its total capital for R$ 45 per share.

In accordance with Brazilian law, Arcelor will launch a "tag along" tender offer for the acquisition of the remaining common shares issued by Acesita for 80% of the average price paid to Previ, Petros and Sistel.

Acesita is one of the most competitive and profitable stainless steel producers in the world. The move is a reflection of Arcelor's longstanding commitment to Brazil, a high quality and low cost production base for steel products with attractive domestic and export markets.

Arcelor has been constantly strengthening its positions in Brazil and Argentina since its inception in 2002, becoming Latin America's leading steel producer. The company is one of the largest global producers of flat stainless steel products with major operations in Europe and in Brazil and a global market presence.

The closing of the Acquisition is subject to the approval of the Brazilian Secretaria de Previdência Complementar (SPC) and from certain non-Brazilian anti-trust authorities.

http://www.arcelor.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.